Page last updated: 2024-10-31

metyrapone and Thromboembolism

metyrapone has been researched along with Thromboembolism in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Thromboembolism: Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dal Bo Zanon, R1
Fornasiero, L1
Boscaro, M1
Ruffato, G1
Luzzato, G1
Fabris, F1
Girolami, A1
Delaney, JP1
Solomkin, JS1
Jacobson, ME1
Doe, RP1

Other Studies

2 other studies available for metyrapone and Thromboembolism

ArticleYear
Clotting changes in Cushing's syndrome: elevated factor VIII activity.
    Folia haematologica (Leipzig, Germany : 1928), 1983, Volume: 110, Issue:2

    Topics: Adrenalectomy; Blood Coagulation; Blood Coagulation Tests; Cushing Syndrome; Factor VIII; Female; Hu

1983
Surgical management of Cushing's syndrome.
    Surgery, 1978, Volume: 84, Issue:4

    Topics: Adenoma; Adolescent; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocorticotropic Ho

1978